| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| 177lu-dotatate | somatostatin receptor type 4 | NA | Clinical trial target | TTD , DGIDB | Hepatitis C[MeSHID:D006526] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
9.09 | phase 2 | unknown |
| click here to return to the previous page | ||||||||